Literature DB >> 21691442

Pulmonary arterial hypertension in children: Diagnostic work-up and challenges.

E B Rosenzweig1, J A Feinstein, T Humpl, D D Ivy.   

Abstract

The diagnostic evaluation of a pediatric patient with suspected pulmonary arterial hypertension (PAH) is extensive but essential, given the rapid progression of the disease if left undiagnosed and untreated. The major goals of performing a complete diagnostic work-up are to confirm the diagnosis of PAH, assess disease severity, rule out associated diseases, and begin to formulate an individualized treatment plan for the pediatric patient with pulmonary hypertension. This article will provide a comprehensive review of the diagnostic work-up of the child with suspected PAH as well as a review of some of the challenges faced when assessing a child for PAH.

Entities:  

Year:  2009        PMID: 21691442      PMCID: PMC3117303          DOI: 10.1016/j.ppedcard.2009.09.003

Source DB:  PubMed          Journal:  Prog Pediatr Cardiol        ISSN: 1058-9813


  39 in total

1.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

2.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

3.  Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

Authors:  Anna Fijalkowska; Marcin Kurzyna; Adam Torbicki; Grzegorz Szewczyk; Michal Florczyk; Piotr Pruszczyk; Monika Szturmowicz
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

4.  Echocardiographic features of primary pulmonary hypertension.

Authors:  D J Goodman; D C Harrison; R L Popp
Journal:  Am J Cardiol       Date:  1974-03       Impact factor: 2.778

5.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

6.  Electrocardiogram in primary pulmonary hypertension.

Authors:  N Kanemoto
Journal:  Eur J Cardiol       Date:  1981

7.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

Authors:  Ronald J Raymond; Alan L Hinderliter; Park W Willis; David Ralph; Edgar J Caldwell; William Williams; Neil A Ettinger; Nicholas S Hill; Warren R Summer; Bennett de Boisblanc; Todd Schwartz; Gary Koch; Linda M Clayton; Maria M Jöbsis; James W Crow; Walker Long
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

8.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

9.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Michael McGoon; David Gutterman; Virginia Steen; Robin Barst; Douglas C McCrory; Terry A Fortin; James E Loyd
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

10.  Antinuclear antibodies in primary pulmonary hypertension.

Authors:  S Rich; K Kieras; K Hart; B M Groves; J D Stobo; B H Brundage
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

View more
  16 in total

Review 1.  Pulmonary arterial hypertension: a comparison between children and adults.

Authors:  R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal:  Eur Respir J       Date:  2011-03       Impact factor: 16.671

Review 2.  Drug treatment of pulmonary hypertension in children.

Authors:  Erika E Vorhies; David Dunbar Ivy
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

Review 3.  B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.

Authors:  Chantal A Ten Kate; Dick Tibboel; Ulrike S Kraemer
Journal:  Eur J Pediatr       Date:  2015-08-23       Impact factor: 3.183

4.  Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry.

Authors:  Kevin D Hill; D Scott Lim; Allen D Everett; D Dunbar Ivy; J Donald Moore
Journal:  Catheter Cardiovasc Interv       Date:  2010-11-15       Impact factor: 2.692

5.  Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.

Authors:  Gang Li; Li Tang; Peng Jia; Jian Zhao; Dong Liu; Bin Liu
Journal:  Pediatr Cardiol       Date:  2015-12-29       Impact factor: 1.655

6.  Medical therapy for pediatric pulmonary arterial hypertension.

Authors:  Cecile Tissot; David Dunbar Ivy; Maurice Beghetti
Journal:  J Pediatr       Date:  2010-07-24       Impact factor: 4.406

7.  Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.

Authors:  Michael E Yeager; Kelley L Colvin; Allen D Everett; Kurt R Stenmark; D Dunbar Ivy
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

Review 8.  Drug Treatment of Pulmonary Hypertension in Children.

Authors:  Catherine M Avitabile; Erika E Vorhies; David Dunbar Ivy
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

Review 9.  Pediatric pulmonary arterial hypertension.

Authors:  Dan-Chen Wu; Hong-Da Zhang; Zhi-Cheng Jing
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 10.  Current challenges in pediatric pulmonary hypertension.

Authors:  Shinichi Takatsuki; David Dunbar Ivy
Journal:  Semin Respir Crit Care Med       Date:  2013-09-13       Impact factor: 3.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.